A multiplex PCR assay was developed to screen blood cultures from children in The Gambia with suspected pneumonia for the simultaneous detection of Haemophilus influenzae type b and Streptococcus pneumoniae isolates. Analysis of 295 blood cultures showed that PCR detected the organisms in all samples positive by culture in two samples infected with H. influenzae type b and four samples infected with S. pneumoniae that were culture negative, indicating that this method is sensitive for detecting these organisms in blood cultures.
An Haemophilus influenzae type b conjugate vaccine trial was recently concluded in The Gambia. One of the main endpoints of the trial was the incidence of H. influenzae type b pneumonia in children enrolled in the study. Children were assessed for pneumonia by using the World Health Organization criteria: cough or difficult breathing and a respiration rate of 50 breaths per minute or more in children ages 2 to 11 months or 40 breaths per minute or more in children ages 12 to 59 months. However, the children enrolled in the study were seen by physicians whenever they were ill, and blood was cultured for conditions other than pneumonia. Therefore, the blood cultures tested in the present study were not exclusively for suspected cases of pneumonia.
PCR was introduced into the study as a sensitive means of detection of H. influenzae type b. It was envisaged that the technique would be able to detect a few more cases of H. influenzae type b infection than culture, thereby increasing the power of the detection method in the trial for the pneumonia endpoint. Previous studies in The Gambia have shown that H. influenzae type b and Streptococcus pneumoniae are the two organisms most likely to be isolated from clinical samples from children with suspected pneumoniae (2, 3, 5) . It was therefore decided to screen blood cultures from the trial for both H. influenzae type b and S. pneumoniae. In this way it was reasoned that the vaccination trial would provide a forum for testing not only the sensitivity of PCR but also the robustness of the technique in this environment.
It was initially intended that buffy coat DNA obtained from EDTA-treated samples would be used for PCR analysis in the vaccination trial study. The feasibility of this approach was first investigated by comparing the PCR results obtained by using DNA extracted from EDTA-treated blood and blood culture samples obtained from 8 patients whose culture results were positive for H. influenzae type b and from 15 patients whose culture results were positive for S. pneumoniae. Prior to DNA extraction, erythrocytes were removed from samples by dextran sedimentation to eliminate a possible inhibitory effect by heme compounds on the PCR. Pellets obtained from supernatants devoid of erythrocytes were used for DNA extraction (4) . Separate PCR assays were used to detect H. influenzae type b Amplification in an automated thermal cycler consisted of 35 cycles with the following parameters: (i) denaturation for 2 min at 95ЊC, (ii) annealing for 2 min at 55ЊC, and (iii) extension for 2 min at 72ЊC. After 35 cycles the samples were incubated for a further 6 min at 72ЊC and were then stored at 4ЊC until they were analyzed. Samples for PCR were prepared in a laminar flow hood (Gelair Flow Laboratory) in an area dedicated to PCR to minimize the risk of contamination. Amplified PCR products of 480 bp for H. influenzae type b and 247 bp for S. pneumoniae were detected by agarose gel electrophoresis.
A poor correlation was observed between the results of PCR with DNA from EDTA-treated samples and culture results. Of the 8 cultures positive for H. influenzae type b, only 2 were positive by PCR, and of 15 cultures positive for S. pneumoniae, only 5 were positive by PCR. In contrast, results of PCR with DNA extracted from blood culture samples showed complete concordance with culture results for both organisms. One drawback with the EDTA-treated samples was that only a small amount of blood was available for testing: in most cases, less than 0.5 ml compared with the 1 to 2 ml that was inoculated into blood culture bottles (20 ml each of tryptic soy broth or brain heart infusion broth [Becton Dickinson]). These were in turn incubated at 37ЊC for up to 7 days before they were made available for DNA extraction and subsequent PCR analysis. It is therefore possible that the majority of the EDTAtreated samples had no bacterial organisms to start with. There was considerable limitation to the amount of blood that could be obtained from children who were the subjects involved in the study. Consequently, it was decided that blood culture samples would provide the most appropriate choice for DNA extraction in the PCR study.
Two blood cultures were routinely set up for each patient: one for aerobic growth of organisms and the other for anaerobic growth of organisms. Detection of the two types of organisms in each patient would therefore require the performance of four separate PCR assays. The amplified products for these two organisms, 480 bp (H. influenzae type b) and 247 bp (S. pneumoniae), were so distinct as to remove any possibility of misdiagnosis. We therefore considered the possibility of multiplexing the PCR assays in order to reduce by half the number of assays for each patient. Preliminary experiments by the multiplex PCR assay established that the four primers for the simultaneous detection of H. influenzae type b and S. pneumoniae organisms were not complementary, giving rise to primer dimers. However, it was observed that there was some loss in the intensity of the signal, with the lower limit of detection being reached for both organisms (5 CFU for H. influenzae type b and 3 CFU for S. pneumoniae) with the multiplex assay compared with that with the individual assays. This situation was rectified by increasing the concentration of Taq polymerase from 2.5 to 3 U/100 l of reaction mixture. Application of the multiplex assay to 295 blood culture samples from 162 patients, some of whom were investigated on more than one occasion, showed that the results of the multiplex PCR were in complete concordance with culture results. The isolation rate may appear low (two patients with H. influenzae type b infection and three patients with S. pneumoniae infection); however, it must be emphasized that not all of these patients were investigated for suspected pneumonia. They may have been ill with conditions other than pneumonia. PCR-positive, culture-negative results were obtained for two additional samples for H. influenzae type b and for three additional samples for S. pneumoniae. In terms of diagnosis, PCR was able to detect H. influenzae type b infection in three patients, whereas culture detected infection in two patients. PCR was able to detect S. pneumoniae infection in five patients, whereas culture detected infection in three patients. However, in one of the last group of patients, diagnosis of S. pneumoniae infection was made by culture of a lung aspirate sample. An additional 30 blood culture samples that had been positive for either H. influenzae type b or S. pneumoniae and stored at Ϫ20ЊC for periods ranging from 1 to 6 months were also analyzed by the multiplex PCR assay. PCR results were concordant with those of culture for 16 samples (6 infected with H. influenzae type b and 10 infected with S. pneumoniae) stored at Ϫ20ЊC for 1 to 3 months. Surprising results were obtained, however, for the remaining 14 culture-positive samples (7 each infected with H. influenzae type b and S. pneumoniae) stored at Ϫ20ЊC for 3 to 6 months. Only five of these samples (two infected with H. influenzae, three infected with S. pneumoniae) were positive by PCR. The reason for this is not clear, but it would appear that prolonged storage of blood culture samples can lead to a deterioration in the quality of DNA required for PCR analysis. Screening of these stored samples also revealed that a patient who had been positive for S. pneumoniae by culture was dually infected with both H. influenzae type b and S. pneumoniae organisms. This result (Fig. 1) as well as all positive PCR results were confirmed by Southern blot hybridization. The probe for confirmation of H. influenzae type b infection was generated by PCR with DNA extracted from an H. influenzae type b isolate. The amplified 480-bp fragment was excised from a low-melting-temperature agarose gel, and the DNA was recovered by treatment with Gelase (Epicenter Technology). A total of 25 ng of the DNA was labelled with [␣-32 P]dCTP by using the megaprime labelling system (Amersham). The probe for confirmation of S. pneumoniae infection was a 21-bp DNA fragment (TTA-CTT-CAG-CTA-ATA-GTG-ACC) located within the amplified PCR product. The probe was end labelled with [␥-32 P]ATP (Amersham) with polynucleotide kinase (U.S. Biochemicals). After overnight transfer of DNA from agarose gels to GeneScreen plus membranes (NEN Research Products) with a 10ϫ SSC buffer (1.5 M sodium chloride plus 0.15 M sodium citrate), the membranes were hybridized with the respective labelled probe for 14 h at 55ЊC in 5ϫ SSC-0.5% sodium dodecyl sulfate (SDS)-5ϫ Denhardt's solution-100 g of sheared denatured salmon sperm DNA per ml-50 pmol of 32 P-labelled probe. After hybridization the membranes were washed twice in 2ϫ SSC-0.1% SDS at room temperature for 10 min and twice in 2ϫ SSC-0.5% SDS at 55ЊC for 15 min. Autoradiography was performed at Ϫ70ЊC on Kodak XAR5 X-ray film for 24 to 48 h.
The multiplex PCR assay has proved to be as sensitive as culture, if not more so, for the detection of H. influenzae type b and S. pneumoniae DNAs in blood culture samples. PCRpositive, culture-negative results were obtained on a number of occasions. While the possibility that these were false-positive results cannot be completely excluded, this would seem unlikely because all PCR results were confirmed by Southern blot hybridization. Furthermore, on one occasion in which a PCRpositive, culture-negative result was obtained for blood culture samples, a diagnosis of S. pneumoniae was established in this patient by culture of a lung aspirate sample. This probably reflects the findings from a number of studies which have shown that the yields for both H. influenzae type b and S. pneumoniae are higher from culture of lung aspirates than cultures of blood (7, 8) . The PCR result could therefore represent a clear manifestation of the exquisite sensitivity of the technique. The multiplex approach could also be useful for diagnosing cases of meningitis caused by either H. influenzae type b or S. pneumoniae (6) . Cerebrospinal fluid samples should be much easier to process than blood samples.
In summary, we have used a multiplex PCR assay to screen blood culture samples for the simultaneous detection of H. influenzae type b and S. pneumoniae DNAs. Multiplexing did not compromise the sensitivity of the technique, and our intention of reducing the number of assays per patient in the study was realized. 
